Description

Additional reference material from the review on probiotics in critically ill children presents compiled evidence on probiotic efficacy and safety in this vulnerable patient population.

Figure 45

Source Paper

Probiotics in critically ill children.

F1000Research (2016)

PMID: 27081478

DOI: 10.12688/f1000research.7630.1

Cite This Figure

![Figure 45: Additional reference material from the review on probiotics in critically ill children presents compiled evidence on probiotic efficacy and safety in this vulnerable patient population.]()

> Source: Sunit C Singhi et al. "Probiotics in critically ill children.." *F1000Research*, 2016. PMID: [27081478](https://pubmed.ncbi.nlm.nih.gov/27081478/)

<figure>
  <img src="" alt="Additional reference material from the review on probiotics in critically ill children presents compiled evidence on probiotic efficacy and safety in this vulnerable patient population." />
  <figcaption>Figure 45. Additional reference material from the review on probiotics in critically ill children presents compiled evidence on probiotic efficacy and safety in this vulnerable patient population.<br>  Source: Sunit C Singhi et al. "Probiotics in critically ill children.." <em>F1000Research</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27081478/">27081478</a></figcaption>
</figure>

Related Evidence

Lactobacillus casei for Antibiotic-Associated Diarrhea (AAD)

Grade C · 3 studies